Physician profile
Yan Wang
NPI 1912256033
$530.68
in general payments reported to CMS, 2019-2025
11 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.63 · 2022: $186 · 2023: $48.02 · 2024: $120 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $123.75 | 2021-2022 | |
| Incyte Corporation | $110.96 | 2024-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $64.82 | 2022-2024 | |
| Arcutis Biotherapeutics, INC. | $41.20 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $40.00 | 2022 | |
| Genzyme Corporation | $38.42 | 2024-2025 | |
| Dermavant Sciences, INC. | $28.10 | 2024 | Vtama |
| Amgen INC. | $25.53 | 2023 | Otezla |
| Regeneron Healthcare Solutions, INC. | $21.13 | 2025 | Dupixent |
| Novo Nordisk INC | $18.71 | 2022 | |
| Leo Pharma INC. | $18.06 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.